Petros Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PTPI research report →
Companywww.petrospharma.com
Petros Pharmaceuticals, Inc. , a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED).
- CEO
- Joshua N. Silverman
- IPO
- 2020
- Employees
- 18
- HQ
- New York City, NY, US
Price Chart
Valuation
- Market Cap
- $190.08K
- P/E
- 0.09
- P/S
- 0.00
- P/B
- 0.16
- EV/EBITDA
- 1.21
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.44%
- ROIC
- -237.69%
Growth & Income
- Revenue
- $0 · -100.00%
- Net Income
- $1.91M · 113.36%
- EPS
- $6.82 · 304.19%
- Op Income
- $-4,641,350
- FCF YoY
- -156.30%
Performance & Tape
- 52W High
- $0.09
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 1.93
- Avg Volume
- 107.65K
Get TickerSpark's AI analysis on PTPI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 2, 26 | Boctor Fady | other | 500,000 |
| Jan 2, 26 | Silverman Joshua | other | 4,375,000 |
| Jan 2, 26 | WALKER WAYNE REMELL | other | 500,000 |
| Jan 2, 26 | Bernstein Bruce | other | 1,875,000 |
| Feb 19, 25 | WALKER WAYNE REMELL | other | 150,000 |
| Feb 19, 25 | Arnold Mitchell | other | 150,000 |
| Feb 19, 25 | Silverman Joshua | other | 1,000,000 |
| Feb 19, 25 | Boctor Fady | other | 450,000 |
| Feb 19, 25 | Bernstein Bruce | other | 300,000 |
| Dec 21, 23 | Bernstein Bruce | other | 40,000 |
Our PTPI Coverage
We haven't published any research on PTPI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate PTPI Report →